FDA Investigator: Rachel C. Harrington
- Rachel C. Harrington first started conducting FDA inspections in 2008, with the last inspection in 2018. Over that time, Rachel C. Harrington has conducted 97 inspections at 66 companies across 72 sites.
Documents
FDA 483 Hanlim Pharm, Yonginsi Ceoin-gu | February 2018
Available - $199
Rachel C. Harrington
Human Drug Form 483
FDA 483 WES Pharma, Westminster | November 2015
Available - $199
Rachel C. Harrington
Human Drug Form 483
FDA 483 Bell-More Laboratories, Hampstead | March 2015
Available - $199
Rachel C. Harrington
Human Drug Form 483
FDA 483 PharmaLogic CSP, Bridgeport | December 2014
Available - $199
Rachel C. Harrington
Human Drug Form 483
FDA 483 FVS Holdings, . dba. Green Valley Drugs | Mar 2013
Available - $199
Rachel C. Harrington
Human Drug Form 483
FDA 483 RX South DBA RX3 Pharmacy, Chester | December 2012
Available - $199
Rachel C. Harrington
Human Drug Form 483
FDA 483 Ningbo Pulisi Daily Chemical Products Co., Ltd, Yuyao City | 2016
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Elkton | 2015
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Wockhardt Limited, Aurangabad | 2015
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Actavis Mid-Atlantic, LLC., Owings Mills | 2014
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 UPM Pharmaceuticals, Bristol | 2014
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 UPM Pharmaceuticals, Baltimore | 2014
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Eisai, Inc., Baltimore | 2013
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Elkton | 2013
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Pharmaceutics International, Inc., Cockeysville | 2013
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Lincare Inc., Westminster | 2013
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Intervet International GmbH, Unterschleisheim | 2013
Out-of-stock
Rachel C. Harrington
Animal Drugs & Feed Form 483
FDA 483 Intervet International GmbH, Unterschleissheim | 2013
Out-of-stock
Rachel C. Harrington
Animal Drugs & Feed Form 483
FDA 483 Zoetis Belgium SA, Louvain-la-Neuve | 2013
Out-of-stock
Rachel C. Harrington
Animal Drugs & Feed Form 483
FDA 483 Zoetis Belgium SA, Louvain-La-Neuve | 2013
Out-of-stock
Rachel C. Harrington
Animal Drugs & Feed Form 483
FDA 483 Pharmaceutics International, Inc., Hunt Valley | 2013
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Bell-More Laboratories Inc, Hampstead | 2013
Out-of-stock
Rachel C. Harrington
Animal Drugs & Feed Form 483
FDA 483 American Antibiotics, Inc., Baltimore | 2013
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Tishcon Corporation, Salisbury | 2013
Out-of-stock
Rachel C. Harrington
Foods & Cosmetic Form 483
FDA 483 Tishcon Corporation, Salisbury | 2013
Out-of-stock
Rachel C. Harrington
Foods & Cosmetic Form 483
FDA 483 Johns Hopkins University PET Center, Baltimore | 2013
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 UPM Pharmaceuticals, Baltimore | 2012
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Pharmaceutics International, Inc., Hunt Valley | 2012
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Ajinomoto Company Inc., Kawasaki-shi | 2012
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Kongo Chemical Co., LTD., Toyama City | 2012
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 K J I Industrial Co., Ltd., Yangsan-si | 2012
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Iba Molecular North America, Inc., Morgantown | 2012
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Cangene bioPharma, Inc., Baltimore | 2012
Out-of-stock
Rachel C. Harrington
Human Drug Form 483
FDA 483 Bioreliance Corporation, Rockville | 2012
Out-of-stock
Rachel C. Harrington
Animal Drugs & Feed Form 483
Co-Investigators (41)
- Tajah L. Blackburn, FDA Investigator
- Jessica L. Pressley, FDA Investigator
- Jonathan W. Chapman, FDA Investigator
- Qin Xu, FDA Investigator
- Junho Pak, FDA Investigator
- Patric C. Klotzbuecher, FDA Investigator
- Steven P. Donald, FDA Investigator
- Doan T. Nguyen, FDA Investigator
- Mujadala M. Abdul-Majid, FDA Investigator
- Scott T. Panagiotis, FDA Investigator
- Nebil A. Oumer, FDA Investigator
- Brooke K. Higgins, FDA Investigator
- Chiang Syin, FDA Investigator
- Laurissa S. Flowers, FDA Investigator
- Shusheen A. Alexander, FDA Investigator
- Henry K. Lau, FDA Investigator
- Joshua S. Hunt, FDA Investigator
- Natasha A. Dezinna, FDA Investigator
- Julie A. Silberberg, FDA Investigator
- Anthony F. Lorenzo, FDA Investigator
- Nawab A. Siddiqui, FDA Investigator
- Ernest Bizjak, FDA Investigator
- Don H. Bark, FDA Investigator
- Susan E. Polifko, FDA Investigator
- William A. Warnick, FDA Investigator
- Edward P. Potter, FDA Investigator
- Krista N. Flores, FDA Investigator
- Stacey A. Priest, FDA Investigator
- Monique-Rac Lester, FDA Investigator
- James W. Leonette, FDA Investigator
- Sharon K. Thoma, FDA Investigator
- Cynthia A. Harris, FDA Investigator
- David P. Rice, FDA Investigator
- Merideth K. Rose, FDA Investigator
- Olaide Akinmade, FDA Investigator
- Hector J. Colon-Torres, FDA Investigator
- Stephanie L. Shapley, FDA Investigator
- Cornelius Brown, FDA Investigator
- Gale L. Glinecki, FDA Investigator
- Patricia A. Morrow, FDA Investigator
- Joseph W. Matthews, FDA Investigator